Skip to Content

'
Issa F. Khouri, M.D.

Present Title & Affiliation

Primary Appointment

Professor Medicine & Internist, Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Bone Marrow Center Medical Director, The University of Texas MD Anderson Cancer Center, Houston, TX

Office Address

The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd.
Unit Number: Box 423
Houston, TX 77030-4095
Phone: (713) 792-8750
Fax: (713) 794-4902

Education & Training

Degree-Granting Education

1983 University of Rome, "La Sapienza", Rome, Italy, MD, Internal Medicine

Postgraduate Training

1989-1993 Fellowship, The University of Texas MD Anderson Cancer Center, Houston, TX
1988-1989 Chief Resident Internal Medicine Residency, North Eastern Ohio University College of Medicine, Rootstown, OH
1987-1989 Internal Medicine Residency, North Eastern Ohio University College of Medicine, Rootstown, OH
1986-1987 Transitional Residency, North Eastern Ohio University of College of Medicine, Rootstown, OH
1985-1986 Graduate, Medical Sciences, Medical College of Ohip at Toledo, Toledo, OH

Honors and Awards

2007 M. D. Anderson/Division of Medicine Nominee for Clinical research Award
2006 M. D. Anderson/Division of Medicine Nominee for Clinical research Award
2003 The Berlex Oncology Award in Patient-Oriented Research. Advisor to the first Place winner of the Seventh Annual Trainee Recognition Day at The M. D. Anderson Cancer Center
1993 M. D. Anderson Annual Clinical Training Research Project Competition
1991-1992 M. D. Anderson Research Funds Competition Recipient

Selected Publications

Peer-Reviewed Original Research Articles
1. Kebriaei P, Madden T, Kazerooni R, Wang X, Thall PF, Ledesma C, Nieto Y, Shpall EJ, Hosing C, Qazilbash M, Popat U, Khouri I, Champlin RE, Jones RB, Andersson BS. Intravenous Busulfan Plus Melphalan Is a Highly Effective, Well-Tolerated Preparative Regimen for Autologous Stem Cell Transplantation in Patients with Advanced Lymphoid Malignancies. Biol Blood Marrow Transplant 17(3):412-20, 3/2011. e-Pub 7/30/2010. PMID: 20674757.
2. Efebera YA, Qureshi SR, Cole SM, Saliba R, Pelosini M, Patel RM, Koca E, Mendoza FL, Wang M, Shah J, Alousi A, Hosing C, Popat U, Kebriaei P, Anderlini P, Khouri IF, Champlin R, Giralt S, Qazilbash MH. Reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed multiple myeloma. Biol Blood Marrow Transplant 16(8):1122-9, 8/2010. e-Pub 2/21/2010. PMID: 20178853.
3. Duvic M, Donato M, Dabaja B, Richmond H, Singh L, Wei W, Acholonu S, Khouri I, Champlin R, Hosing C. Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome. J Clin Oncol 28(14):2365-72, 5/10/2010. e-Pub 3/29/2010. PMID: 20351328.
4. Safdar A, Rodriguez GH, Mihu CN, Mora-Ramos L, Mulanovich V, Chemaly RF, Champlin RE, Khouri I. Infections in non-myeloablative hematopoietic stem cell transplantation patients with lymphoid malignancies: spectrum of infections, predictors of outcome and proposed guidelines for fungal infection prevention. Bone Marrow Transplant 45(2):339-47, 2/2010. e-Pub 6/29/2009. PMID: 19561648.
5. Cheng YC, Rondón G, Sanchez LF, McMannis JD, Couriel DR, de Lima MJ, Hosing C, Khouri IF, Giralt SA, Champlin RE, Ueno NT. Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer. Int J Hematol 90(5):627-34, 12/2009. e-Pub 12/9/2009. PMID: 19998065.
6. Popat U, Saliba R, Thandi R, Hosing C, Qazilbash M, Anderlini P, Shpall E, McMannis J, Körbling M, Alousi A, Andersson B, Nieto Y, Kebriaei P, Khouri I, de Lima M, Weber D, Thomas S, Wang M, Jones R, Champlin R, Giralt S. Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma. Biol Blood Marrow Transplant 15(6):718-23, 6/2009. e-Pub 4/8/2009. PMID: 19450756.
7. Hosing C, Saliba RM, Ahlawat S, Körbling M, Kebriaei P, Alousi A, De Lima M, Okoroji JG, McMannis J, Qazilbash M, Anderlini P, Giralt S, Champlin RE, Khouri I, Popat U. Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma. Am J Hematol 84(6):335-7, 6/2009. PMID: 19384931.
8. Tam CS, Khouri I. The role of stem cell transplantation in the management of chronic lymphocytic leukaemia. Hematol Oncol 27(2):53-60, 6/2009. PMID: 19358149.
9. Ramos CA, Saliba RM, de Pádua L, Khorshid O, Shpall EJ, Giralt S, Patah PA, Hosing CM, Popat UR, Rondon G, Khouri IF, Nieto YL, Champlin RE, de Lima M. Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Haematologica 94(2):249-57, 2/2009. e-Pub 1/14/2009. PMCID: PMC2635398.

Last updated: 3/23/2011